Page 12 - Expanded Disability Status Scale News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mitochondrial Dysfunction Linked to MS, Further Studies Needed on Metabolic Impact

More research is necessary to understand cerebral oxygen consumption as a predictive biomarker for brain atrophy in multiple sclerosis (MS); however, this study found that mitochondrial dysfunction could have a role in the underlying pathophysiology of MS.

Cerebral blood flowDegeneration conceptExpanded disability status scaleMultiple sclerosis clinicMultiple sclerosisMetabolic dysfunctionCerebral oxygenRelapsing remitting

Blood levels of GFAP protein may help predict PPMS progression

Blood levels of GFAP protein may help predict PPMS progression
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

University hospital of ulmUniversity hospitalExpanded disability status scale

Ocrevus MS use may help severely disabled patients in real world

Ocrevus MS use may help severely disabled patients in real world
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

United statesWomen multiple sclerosis centerMultiple sclerosisMultiple sclerosis centerExpanded disability status scale

Phase 2 Clinical Trial For SPMS With Intranasal Monoclonal Antibody

Tiziana Life Sciences expects to start enrolling patients for a phase 2a trial of Foralumab, an immunomodulation therapy for Secondary Progressive Multiple Sclerosis that’s administered through the nose.

Tiziana life sciencesSecondary progressive multiple sclerosisEmission tomographyModified fatigue impact scaleExpanded disability status scaleFoot walk testNeuroqol fatigue

Tiziana Life Sciences : Updated Interim Results for the Six Months Ended 30 June 2023 - Form 6-K -December 29, 2023 at 04:39 pm EST

Updated Interim Results for the Six Months Ended 30 June 2023 NEW YORK, December 29, 2023 - Tiziana Life Sciences, Ltd. , a biotechnology company developing breakthrough.

United statesUnited kingdomCity ofTanuja chitnisMatthew davisMonte carloGabriele cerroneSaef izzyWilliama haseltineWilliama clementiPaul spencerIrina kofflerHoward weinerTiziana life sciencesLifesci advisorsPharma ltd